← Back to all substances
R

budesonide

227ms
Level 1

✓ What this shows

  • • Reported adverse events from FDA FAERS
  • • Descriptive statistics from a locked corpus
  • • Data verified with cryptographic hashes

✗ What this is NOT

  • • Not medical advice or recommendations
  • • Not proof of causality
  • • Not a complete safety profile

About this substance

Class: Corticosteroid [EPC]

Use s Temporarily relieves these symptoms of hay fever or other upper respiratory allergies: • nasal congestion • runny nose • itchy nose • sneezing

Known as: Budesonide
Route: NASAL
Source: OpenFDA Drug Labels · Reference only · Not medical advice
500
Events in Corpus
v20260131-01
55,587
Total in FDA
85%
Serious Reports
53
Fatal Outcomes

Seriousness

Serious
427
Non-Serious
73

Sex Distribution

Male
223
Female
258
Unknown
19

Age Distribution

0-17
35
18-40
73
41-64
119
65-84
157
85+
20
Unknown
96

Outcomes

Recovered/Resolved
371
Recovering/Resolving
223
Not Recovered/Not Resolved
217
Recovered with Sequelae
8
Fatal
53
Unknown
887

Top Reported Reactions (click to view reports)

Verification Data

Corpus Version: v20260131-01
Root Hash: ec5727564d1ed19be5b08b26d3866f446b12d3d388f5a8cd713332c6d97ad264
Stats Hash: N/A
EVE Decision ID: EVE-MED-20260402-5d0e07
ℹThis output reports adverse events from FDA FAERS. It does not constitute medical advice.

Molecular Structure (reference)

Structural visualization for identification only.

This visualization shows the molecular structure for identification purposes only. It does not represent pharmacological effect, safety, or clinical relevance.

Loading structure...